Results 201 to 210 of about 20,471 (284)

Influence of the Uncertainty in the Dam‐Breach Hydrograph on the Flood Hazard Assessment in a Valley Area

open access: yesJournal of Flood Risk Management, Volume 19, Issue 2, June 2026.
ABSTRACT The reliability of flood event simulations is a crucial aspect in terms of saving lives. The worst flood scenarios derive from possible dam failures. For earthen dams, the breaching mechanism, triggered by overtopping or piping, is affected by several modelling uncertainties, which propagate downstream and may influence flood hazard mapping ...
Andrea Antonella Graziano   +2 more
wiley   +1 more source

Poor agreement between methods used in population studies to estimate the volume of human milk consumed: a Bland-Altman analysis. [PDF]

open access: yesInt Breastfeed J
Lima Cavalcanti AA   +6 more
europepmc   +1 more source

Development of a Lysine‐Reactive Targeted Covalent Inhibitor for the P300/CBP‐Associated Factor Bromodomain Through Structure‐Based Design

open access: yesChemMedChem, Volume 21, Issue 10, 27 May 2026.
We developed a targeted covalent inhibitor for the p300/CBP‐associated factor (PCAF) bromodomain. Our lead molecule, 10, labeled a unique lysine residue in the PCAF bromodomain, demonstrated potent inhibition in biophysical/biochemical assays, and engaged the PCAF bromodomain in cells.
Richard R. Ede   +9 more
wiley   +1 more source

Identification of 2‐Substituted‐3‐Hydroxy‐2,3‐Dihydroquinazolin‐4(1H) Ones as Cell‐Active Inhibitors of KDM4A Lysine Demethylase

open access: yesChemMedChem, Volume 21, Issue 10, 27 May 2026.
A novel 3‐hydroxy‐2,3‐dihydroquinazolinone scaffold is identified as a cell‐active KDM4A inhibitor through an orthogonal screening cascade minimizing assay interference. Integrated biochemical, biophysical, and proteomic validation reveals compound 6i as a bona fide binder that increases H3K9 methylation in cells, highlighting both a promising ...
Alessandra Feoli   +13 more
wiley   +1 more source

Synergistische Entwicklungsstrategien von Inhibitoren gegen humane UDP‐Galactose‐4‐Epimerase

open access: yesAngewandte Chemie, Volume 138, Issue 22, 25 May 2026.
Die Epimerase GalE ist essenziell für die Biosynthese von krebsrelevanten O‐GalNAc Glykanen. Wir verwenden orthogonales, strukturbasiertes Screening niedermolekularer Fragmente an, um kovalente und nichtkovalente Inhibitoren gegen GalE mit nicht mehr als 22 optimierten Verbindungen zu erhalten.
William M. Browne   +22 more
wiley   +1 more source

Home - About - Disclaimer - Privacy